A leader in CNS specialty medicine sales in the United States and in the top five globally, Teva Pharmaceuticals is actively looking to expand its CNS portfolio further.

examination, and medical decision-making. The manual defines medical decision-making as diagnosing and selecting management options. Analyze whether the service the CNS provides or wishes to ...

Based on the examination, the problem can be traced to, for example, a specific area of the brain, the peripheral nervous system or part of the spine. Any necessary further investigations are then ...

Physical examination revealed no pertinent abnormalities, and complete blood counts, liver-function studies, determinations of blood urea nitrogen and electroencephalograms were all within normal ...

Stephen Collins as its new Chief Medical Officer, succeeding Dr. Mark A. Smith, who will remain as an advisor. Dr. Collins brings significant expertise in CNS drug development, which aligns with ...